Home Newsfeeds Exane BNP Paribas Initiates Coverage On DraftKings with Underperform Rating

Exane BNP Paribas Initiates Coverage On DraftKings with Underperform Rating

Exane BNP Paribas analyst Alistair Johnson initiates coverage on DraftKings (NASDAQ:DKNG) with a Underperform rating.

byBenzinga Newsdesk

October 6, 2022

1 minute read

Exane BNP Paribas analyst Alistair Johnson initiates coverage on DraftKings (NASDAQ:DKNG) with a Underperform rating.

Ashford Q3 EPS $1.48 Beats $1.35 Estimate, Sales $164.61M Beat $148.20M Estimate

By Benzinga Newsdesk

November 3, 2:13 AM

Ashford (AMEX:AINC) reported quarterly earnings of $1.48 per share which beat the analyst consensus estimate of $1.35 by 9.63 percent. This is a 33.33 percent increase over earnings of $1.11 per share from the same

AINC

AMD Grabs 33% of Server CPU Market and Prepares for Major Processor Launch: Report

By Anusuya Lahiri

May 28, 8:48 AM

AMD claims 33% share in server CPU market, prepares for launch of new processors & unveils GPU roadmap. CFO highlights partnerships & growth in all segments.

AMD

Pfizer’s Paxlovid Demonstrates Safety But Raises Questions on Efficacy in Low-Risk Covid-19 Patients-NEJM Study

By Vandana Singh

April 5, 1:28 PM

New England Journal of Medicine publishes Pfizer's Paxlovid trial data, revealing insights into COVID-19 treatment efficacy, hospitalization rates, and adverse events. Learn more about the study's findings and implications.

PFE

Top 5 Tech And Telecom Stocks That Could Blast Off In Q4

By Lisa Levin

November 24, 9:10 AM

The most oversold stocks in the communication services sector presents an opportunity to buy into undervalued companies.

GAMB

Exane BNP Paribas Initiates Coverage On DraftKings with Underperform Rating

Related Posts

Ashford Q3 EPS $1.48 Beats $1.35 Estimate, Sales $164.61M Beat $148.20M Estimate

AMD Grabs 33% of Server CPU Market and Prepares for Major Processor Launch: Report

Pfizer’s Paxlovid Demonstrates Safety But Raises Questions on Efficacy in Low-Risk Covid-19 Patients-NEJM Study

Top 5 Tech And Telecom Stocks That Could Blast Off In Q4